The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Western blot analysis of eNOS (pT495). A human endothelial cell lysate (lane 1), recombinant eNOS protein before in vitro phosphorylation of Thr-495 (lane 2), and recombinant eNOS protein after in vitro phosphorylation of Thr-495 with PKA kinase (lane 3) was probed with a 1:1000 dilution of the mouse anti-eNOS (pT495) antibody. eNOS (pT495) may be observed to be migrating at ~ 140 kDa.
Western blot analysis of eNOS (pT495). A human endothelial cell lysate (lane 1), recombinant eNOS protein before in vitro phosphorylation of Thr-495 (lane 2), and recombinant eNOS protein after in vitro phosphorylation of Thr-495 with PKA kinase (lane 3) was probed with a 1:1000 dilution of the mouse anti-eNOS (pT495) antibody. eNOS (pT495) may be observed to be migrating at ~ 140 kDa.
Western blot analysis of eNOS (pT495). A human endothelial cell lysate (lane 1), recombinant eNOS protein before in vitro phosphorylation of Thr-495 (lane 2), and recombinant eNOS protein after in vitro phosphorylation of Thr-495 with PKA kinase (lane 3) was probed with a 1:1000 dilution of the mouse anti-eNOS (pT495) antibody. eNOS (pT495) may be observed to be migrating at ~ 140 kDa.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Western blot: Please refer to http://www.bdbiosciences.com/pharmingen/protocols/Western_Blotting.shtml
Nitric oxide synthase (NOS), a cell-type specific enzyme, catalyzes the synthesis of nitric oxide (NO). NO is a short-lived radical that transmits signals involved in vasorelaxation, neurotransmission, and cytotoxicity. In neurons and endothelial cells, constitutive NOS (cNOS) is activated by agonists that increase intracellular Ca2+ levels and enhance calmodulin binding. Neuronal NOS (nNOS) and endothelial NOS (eNOS) have recognition sites for NADPH, FAD, FMN, and calmodulin. eNOS has a unique N-myristylation consensus sequence that may explain its membrane localization. Various protein kinases have been implicated in regulation of eNOS activity, including AMPK, PKA, PKB/Akt, PKC, and CaM Kinase II. During VEGF stimulation, eNOS is transiently phosphorylated at Ser-1177 by PKB/akt and dephosphorylated at Thr-495. At later time points, VEGF stimulation leads to an increase in Thr-495 phosphorylation mediated by PKC and a decrease in Ser-1177 phosphorylation. In addition, Ser-495, Ser-633, and Ser-1177 are phosphorylated by PKA and PKG in vitro. Thus, eNOS activity may be regulated through complex phosphorylation events mediated by multiple kinases at various phosphorylation sites.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.